Skip to content
Lower risk Medical device recall · FDA · Published August 22, 2023

Encore Medical EMPOWR Hip System Recall: Wrong Parts Risk Surgery Errors

Encore Medical recalls EMPOWR Acetabular System (REF 942-01-40H) due to swapped hip/knee parts in packaging. Surgeons may use incorrect components during surgery. Affected units have specific UDI-DI and lot numbers.

🇺🇸 FDA recall #Z-0103-2024Medical deviceEncore Medical ›
Take action

Contact the company

Recalling firmEncore Medical, LP9800 Metric Blvd · Austin, TX 78758-5445
✎ GovInfoNow plain-language explainer

Encore Medical is recalling its EMPOWR Acetabular System (10° Hooded, HXe+, 40H) because parts were swapped in the packaging. This could lead to surgeons using the wrong components for hip surgery when knee parts were mistakenly included. The recall affects specific units with the listed reference number and expiration date. Read more at govinfonow.com/recall/57460-encore-medical-empowr-hip-system-recall-wrong-parts-risk-surgery.

Source Summary by GovInfoNow · govinfonow.com/recall/57460-encore-medical-empowr-hip-system-recall-wrong-parts-risk-surgery · Updated August 10, 2026 · FDA enforcement record: FDA #Z-0103-2024

Cite this page

“Encore Medical EMPOWR Hip System Recall: Wrong Parts Risk Surgery Errors.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/57460-encore-medical-empowr-hip-system-recall-wrong-parts-risk-surgery. Based on FDA recall #Z-0103-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0103-2024%22&limit=1).

Encore Medical, LP voluntarily recalled the EMPOWR Acetabular System Liner on August 22, 2023, according to the FDA. The recall was announced because knee insert and acetabular system parts were swapped within inner packs prior to sealing. This error could result in surgeons not having the correct product for surgery.

How to tell if you have it

  • Brand: Encore Medical
  • Product: EMPOWR Acetabular System, Liner, 10¿ Hooded, HXe+, 40H
  • REF: 942-01-40H
  • UDI-DI: 00190446309833
  • Lot: 629Z1114
  • Expiration: March 30, 2028

The hazard

Knee insert and acetabular system parts were swapped within inner packs prior to the product being sealed within the tray. This could result in surgeons not having the correct product for surgery due to different anatomies (Hip vs Knee).

Context

GovInfoNow's records show Encore Medical, LP has 43 other recalls on record since May 31, 2017. Recent similar recalls include the EMPOWR 3D Knee Ins 11L 14MM VE Product Mix-Up Recall (February 16, 2026) and the Encore Medical RSP Humeral Socket Insert Recall (January 15, 2026). Other recent recalls of similar products include the U2 Total Knee System Femoral Valgus Adaptor Recall (May 20, 2026) and the Smith & Nephew BIOSURE HA Screw Recall (November 24, 2025).

How to tell if you have this one

Check for the reference number 942-01-40H on the product label. The units have a specific UDI-DI (00190446309833) and lot number (629Z1114) with an expiration date of March 30, 2028.

  • Brand
    Encore Medical
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    US Nationwide distribution in the states of FL, CA, IN, HI, LA, MN, AZ, TX, NJ, PA, KS, TN, PR, SC, WA.
Recall numberProduct, codes & lotsQuantity
Z-0102-2024EMPOWR 3D Knee Tibial Insert, 5R, 10MM, VE, REF: 342-10-705; UDI-DI: 00888912167321, Lot: 075T1167, Expiration: March 30, 202836
Z-0103-2024EMPOWR Acetabular System, Liner, 10¿ Hooded, HXe+, 40H, REF: 942-01-40H; UDI-DI: 00190446309833, Lot: 629Z1114, Expiration: March 30, 202820
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the reference number 942-01-40H on the product label to confirm if it's affected.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 14 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: named in the noticeWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: named in the noticeMNIllinois: nationwideILWisconsin: nationwideWIMichigan: nationwideMINew York: nationwideNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: named in the noticeINOhio: nationwideOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: nationwideMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: nationwideMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: nationwideNMKansas: named in the noticeKSArkansas: nationwideARTennessee: named in the noticeTNNorth Carolina: nationwideNCSouth Carolina: named in the noticeSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: named in the noticeLAMississippi: nationwideMSAlabama: nationwideALGeorgia: nationwideGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “US Nationwide distribution in the states of FL, CA, IN, HI, LA, MN, AZ, TX, NJ, PA, KS, TN, PR, SC, WA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Arizona, California, Florida, Hawaii, Indiana, Kansas, Louisiana, Minnesota, New Jersey, Pennsylvania, Puerto Rico, South Carolina, Tennessee, Texas, Washington.

Recall timeline

FDA published this recall 57 days after the firm started it.

1. Firm started the recall: Aug 22, 202312. FDA classified it Class II: Oct 12, 202323. Published in FDA’s Enforcement Report: Oct 18, 202332023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0103-2024 (August 22, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0103-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA